“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

GSK has applied to the US Food and Drug Administration (FDA) to extend use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults under the age of 50 who are at increased risk of the ...

In June, infectious disease physicians sounded the alarm over the Trump administration overstepping existing, transparent processes for changing vaccine recommendations, particularly pointing to new ...

FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.

Kennedy selected a new team of medical professionals and scientists who are highly qualified and dedicated to public health.

The update covers the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, skin cancer ...

What the shingles vaccine does is it dampens reactivations of latent viruses in a way that may be protecting other parts of your body,” Martin said. Including, it seems, the brain. The measles, mumps ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

Six in 10 U.S. adults think that AI-generated health information is somewhat or very reliable, a survey from the Annenberg Public Policy Center finds. But nearly half (49%) are not comfortable with ...

The CDC's Vaccine Recommendations Draw Scrutiny Amid Controversial Changes** In a move that raises eyebrows, the Centers for Disease Control and Prevention (CDC) h ...